XML 43 R28.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock Option Grants Valuation Assumptions
The following table presents the assumptions used in the Monte Carlo simulation model to determine the fair value of these stock-based awards on their issuance date:
 
Risk-free interest rate
     1.5
Expected volatility
     49.0
Expected dividend yield
     0
Derived service period (in years)
     4.1  
Schedule of Stock Options Activity
The following table summarizes the Company’s option activity since December 31, 2019:
 
    
Number of Shares
   
Weighted
Average
Exercise

Price
    
Weighted
Average
Remaining
Contractual
Term
    
Aggregate
Intrinsic

Value
 
                 
(in years)
    
(in thousands)
 
Outstanding as of December 31, 2019
     2,827,868     $ 7.17        6.5      $ 76,850  
Granted
     531,108       45.17                    
Exercised
     (776,914     6.32                    
Forfeited
     (393,143     33.26                    
    
 
 
                           
Outstanding as of December 31, 2020
     2,188,919     $ 12.01        5.72      $ 57,538  
    
 
 
                           
Vested and expected to vest as of December 31, 2020
     2,121,884     $             12.12                        5.71      $           55,616  
    
 
 
                           
Options exercisable as of December 31, 2020
               1,370,762     $ 6.94        4.84      $ 41,689  
    
 
 
                           
Schedule of Unvested Restricted Stock Units
The following table summarizes the Company’s RSU activity since December 31, 2019:
 
    
Number of Shares
   
Weighted Average Grant-
Date Fair Value
 
Unvested balance December 31, 2019
     3,367,846     $ 14.84  
Granted
     1,331,417       42.35  
Vested
     (998,478     16.30  
Forfeited
     (558,565     19.02  
    
 
 
         
Unvested balance December 31, 2020
                         3,142,220     $                          25.29  
    
 
 
         
Summary of Stock-Based Compensation Expense of Statements of Operations and Comprehensive Loss
The Company recorded stock-based compensation expense in the following expense categories of its statements of operations and comprehensive loss (in thousands):
 
    
Year Ended December 31,
 
    
2020
    
2019
 
Cost of revenue
   $ 361      $ 193  
Sales and marketing
     10,246        3,805  
Research and development
     7,751        3,967  
General and administrative
     5,821        4,756  
    
 
 
    
 
 
 
     $                        24,179      $                        12,721